N- alanyl- leucyl- alanyl- leucyl- doxorubicin
extracellularly tumor-activated prodrug for the selective chemotherapy of cancer
Also Known As:
N-beta-alanyl-L-leucyl-L-alanyl-L-leucyl-dox; SLD cpd
Networked: 0
relevant articles (0 outcomes,
0 trials/studies)
Bio-Agent Context: Research Results